To include your compound in the COVID-19 Resource Center, submit it here.

KV Pharmaceutical genitourinary news

In an SEC filing dated April 4, investment fund Adage Capital Partners disclosed that

Read the full 140 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE